Audit Standards

Target (%)

Exception

Results

Guidelines

1) adult patient who are on or recently used high-dose oral or high-dose systemic GC (e.g. more than 7.5 mg prednisolone or equivalent per day for 3 months or longer) should be considered for fracture risk assessment (or BMD testing if patient below 40 years old).

50%

No

Insufficient

information to draw a result.

NICE

2) Optimizing calcium intake (1000 - 1200 mg/day) For all patients receiving GC treatment.

50%

Causes of hypercalcemia and allergies to calcium components.

6.7%

ACR

3) Optimizing vitamin D intake (600 - 800 IU/day) for all patients receiving GC therapy.

50%

Causes of hypercalcemia and vitamin D toxicity

Insufficient

information to draw a result.

ACR

4) Optimizing lifestyle modifications (a balanced diet, maintaining weight in the recommended range, smoking cessation, regular weight bearing or resistance training exercise, limiting alcohol intake to 1 - 2 alcoholic beverages/day ) for all patients receiving GC therapy.

50%

No

15.6%

ACR